Indole based peptidomimetics as anti-inflammatory and anti-hyperalgesic agents: Dual inhibition of 5-LOX and COX-2 enzymes

Samuelsson, 1987, Drugs, 33, 2, 10.2165/00003495-198700331-00003 Davies, 1984, Annu. Rev. Immonol., 2, 335, 10.1146/annurev.iy.02.040184.002003 Minor, 1996, Biochemistry, 35, 10687, 10.1021/bi960576u Vane, 1998, Annu. Rev. Pharmacol. Toxicol., 38, 97, 10.1146/annurev.pharmtox.38.1.97 Haeggstrom, 2011, Chem. Rev., 111, 5866, 10.1021/cr200246d Rouzer, 2003, Chem. Rev., 103, 2239, 10.1021/cr000068x Wenzel, 2003, Prostaglandins Leukot. Essent. Fat. Acids, 69, 145, 10.1016/S0952-3278(03)00075-9 Merched, 2008, FASEB J., 22, 3595, 10.1096/fj.08-112201 Stanke-Labesque, 2008, Inflamm. Bowel Dis., 14, 769, 10.1002/ibd.20403 Gheorghe, 2009, Arthritis Res. Ther., 11, 1, 10.1186/ar2717 S. Izraely, I.P. Witz, P. Larghi, C. Porta, E. Riboldi, P. Allavena, A. Mantovani, A. Sica, L. Bertazza, S. Mocellin, M. DeWitte, E. Voronov, R.N. Apte, E.C. Keeley, B. Mehrad, R.M. Strieter, Y. Li, A. Fulton, A. Ben-Baruch, A. Burkhardt, A. Zlotnik, D. Luger, L.M. Wakefield, A. Peled, Bentham Science Publishers (2012). Carlo, 2009, Mol. Interv., 9, 31, 10.1124/mi.9.1.8 Everts, 2000, Clin. Rheumatol., 19, 331, 10.1007/s100670070024 Rossi, 2010, Br. J. Pharmacol., 161, 555, 10.1111/j.1476-5381.2010.00930.x Sampson, 2009, Curr. Opin. Investig. Drugs, 11, 1163 Dogne, 2005, J. Med. Chem., 48, 2251, 10.1021/jm0402059 Food and Drug Administration, News Release, September 30, 2004 and April 7, 2005. Prasher, 2014, Bioorg. Med. Chem., 22, 1642, 10.1016/j.bmc.2014.01.027 Singh, 2013, Bioorg. Med. Chem. Lett., 23, 1433, 10.1016/j.bmcl.2012.12.068 Cragg, 2014, J. Nat. Prod., 77, 703, 10.1021/np5000796 Rastelli, 2014, J. Med. Chem., 57, 7874, 10.1021/jm5006463 www.molinspiration.com. Maity, 1998, Phytother. Res., 12, 221, 10.1002/(SICI)1099-1573(199805)12:3<221::AID-PTR221>3.0.CO;2-L Sakurada, 2003, Pharmacol. Biochem. Behav., 75, 115, 10.1016/S0091-3057(03)00066-2 Organization for Economic Cooperation and Development (OECD), 2001 5-LOX inhibitor screening assay kit, Item No. 760700. Cayman Chemical Co. Cayman Chemical Co., Cat. No. 560131 (COX-1/2). Chi, 2001, Biochem. Pharmacol., 61, 1195, 10.1016/S0006-2952(01)00597-4 Meade, 1993, J. Biol. Chem., 268, 6610, 10.1016/S0021-9258(18)53294-4 Lipsky, 1997, J. Rheumatol., 24, 9 Blanco, 1999, J. Rheumatol., 26, 1366 Hildebrand, 1949, J. Am. Chem. Soc., 71, 2703, 10.1021/ja01169a008 Castellani, 2009, Neurotox. Res., 15, 49, 10.1007/s12640-009-9004-6 Koon, 2006, J. Immunol., 176, 5050, 10.4049/jimmunol.176.8.5050 Wang, 2010, Bioorg. Med. Chem. Lett., 20, 7159, 10.1016/j.bmcl.2010.07.054 Gilbert, 2012, FASEB J., 26, 3222, 10.1096/fj.12-205286 ArgusLab 4.0.1, M. A. Thompson, Planaria Software LLC, Seattle, WA 98155.